(Q38075544)

28 August 2017

1 reference

title

Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs (English)

1 reference

28 August 2017

1 reference

0 references

2

1 reference

28 August 2017

Heidi M Kieler-Ferguson

object named as

Heidi M Kieler-Ferguson

series ordinal

1

0 references

author name string

Francis C Szoka

series ordinal

3

1 reference

28 August 2017

publication date

17 January 2013

1 reference

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

28 August 2017

published in

1 reference

28 August 2017

volume

5

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

130-138

1 reference

Cytochrome P-450 3A4: regulation and role in drug metabolism

28 August 2017

cites work

1 reference

Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin

21 January 2018

1 reference

Dendritic molecular capsules for hydrophobic compounds.

21 January 2018

1 reference

Prodrug approaches for enhancing the bioavailability of drugs with low solubility

21 January 2018

1 reference

The dawning era of polymer therapeutics

21 January 2018

1 reference

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture

21 January 2018

1 reference

Bio-inspired, bioengineered and biomimetic drug delivery carriers

21 January 2018

1 reference

Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture

21 January 2018

1 reference

Prodrug strategies in anticancer chemotherapy

21 January 2018

1 reference

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

21 January 2018

1 reference

Mechanisms and consequences of cellular cholesterol exchange and transfer.

21 January 2018

1 reference

Fast flip-flop of cholesterol and fatty acids in membranes: implications for membrane transport proteins

21 January 2018

1 reference

Doxil®--the first FDA-approved nano-drug: lessons learned

21 January 2018

1 reference

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

21 January 2018

1 reference

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

21 January 2018

1 reference

Cancer therapies utilizing the camptothecins: a review of the in vivo literature

21 January 2018

1 reference

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin

21 January 2018

1 reference

Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma

21 January 2018

1 reference

Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)

21 January 2018

1 reference

A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

21 January 2018

1 reference

A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies

21 January 2018

1 reference

Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies

21 January 2018

1 reference

XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer

21 January 2018

1 reference

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

Strategies for optimizing combinations of molecularly targeted anticancer agents

21 January 2018

1 reference

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

Central nervous system tumors

21 January 2018

1 reference

Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines

21 January 2018

1 reference

Platinum complexes as anticancer agents

21 January 2018

1 reference

Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.

21 January 2018

1 reference

Direct cellular responses to platinum-induced DNA damage

21 January 2018

1 reference

ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic

21 January 2018

1 reference

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.

21 January 2018

1 reference

Polymeric micellar delivery systems in oncology

21 January 2018

1 reference

The status of platinum anticancer drugs in the clinic and in clinical trials

21 January 2018

1 reference

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

21 January 2018

1 reference

A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer

21 January 2018

1 reference

Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.

21 January 2018

1 reference

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

21 January 2018

1 reference

A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.

21 January 2018

1 reference

Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/WNAN.1209

1 reference

28 August 2017

1 reference